{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T20:49:33Z","timestamp":1779396573135,"version":"3.53.1"},"reference-count":24,"publisher":"BMJ","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"published-print":{"date-parts":[[1994,9]]},"abstract":"<jats:p>AIMS--To determine the type of endometrial abnormalities associated with prolonged tamoxifen treatment and to investigate the correlation between tamoxifen dose and any abnormalities detected. METHODS--Endometria from 19 prospectively collected breast cancer patients treated with tamoxifen were ascribed a pathological diagnosis and the findings compared with those in a control group matched for age and presentation. The abnormalities were related to cumulative tamoxifen dose. RESULTS--The two asymptomatic treated patients had generalised simple endometrial hyperplasia at necropsy. No endometrial abnormalities were seen at necropsy in the two control cases. Of the 17 patients treated with tamoxifen who underwent surgery for gynaecological symptoms, 11 had hyperplastic endometrial polyps characterised by epithelial metaplasias and patchy periglandular condensation of stroma. Two women had primary endometrial malignancies with myometrial invasion, and three women, one of whom had previously presented with a benign polyp, had an endometrial polyp-cancer on a background of hyperplasia. Endometrial malignancies were confined to women who had taken more than 35 g of tamoxifen. The control group included no endometrial polyp-cancers, only one patient with an endometrial polyp, four women with endometrial hyperplasia and four with primary endometrial malignancy. CONCLUSIONS--These findings support a link between prolonged tamoxifen treatment and endometrial malignancy and identify a subgroup of patients--that is, those who have taken more than 35 g of tamoxifen, who may be at increased risk of endometrial cancer. The spectrum of pathological findings in patients treated with tamoxifen suggests that the drug promotes endometrial growth and that endometrial polyps may be an important intermediate step in endometrial carcinogenesis.<\/jats:p>","DOI":"10.1136\/jcp.47.9.827","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:50:46Z","timestamp":1181350246000},"page":"827-833","source":"Crossref","is-referenced-by-count":167,"title":["Pathology of endometrium treated with tamoxifen."],"prefix":"10.1136","volume":"47","author":[{"given":"S M","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1994,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0163-7258(84)90043-3","article-title":"The pharmacology and clinical uses of tamoxifen","volume":"25","author":"Furr, B.J.A.; Jordan, V.C.","year":"1984","unstructured":"Furr BJA, Jordan VC. The pharmacology and clinical uses of tamoxifen. Pharnacol Ther 1984;25:127-205.","journal-title":"Pharnacol Ther"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/bjc.1988.138","article-title":"Controlled trial of tamoxifen as a single adjuvant agent in management of early breast cancer","volume":"57","author":"Baum, M.; Brinkley, D.M.; Dosset, J.A.; McPherson, K.; Jackson, I.M.; Rubens, R.D.","year":"1988","unstructured":"Baum M, Brinkley DM, Dosset JA, McPherson K, Jackson IM, Rubens RD, et al. Controlled trial of tamoxifen as a single adjuvant agent in management of early breast cancer. BrJ Cancer 1988;57:608-11.","journal-title":"BrJ Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/jnci\/83.20.1450","article-title":"Potential role of tamoxifen in prevention of breast cancer","volume":"83","author":"Nayfield, S.G.; Karp, J.E.; Ford, L.G.; Dorr, F.A.; Kramer, B.S.","year":"1991","unstructured":"Nayfield SG, Karp JE, Ford LG, Dorr FA, Kramer BS. Potential role of tamoxifen in prevention of breast cancer. JNCI 1991;83:1450-9.","journal-title":"JNCI"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0140-6736(92)93162-G","article-title":"The case for clinical trials of tamoxifen for prevention of breast cancer","volume":"340","author":"Powles, T.J.","year":"1992","unstructured":"Powles TJ. The case for clinical trials of tamoxifen for prevention of breast cancer. Lancet 1992;340:1145-7.","journal-title":"Lancet"},{"key":"ref_5","first-page":"1351","article-title":"Oestrogen-like effect of tamoxifen on vaginal epithelium","volume":"1","author":"Ferrazzi, E.; Cartei, G.; Mattarazzo, R.; Fiorentino, M.","year":"1977","unstructured":"Ferrazzi E, Cartei G, Mattarazzo R, Fiorentino M. Oestrogen-like effect of tamoxifen on vaginal epithelium. BrMedJ 1977;1:1351-2.","journal-title":"BrMedJ"},{"key":"ref_6","first-page":"281","article-title":"Estrogen-like action of tamoxifen on vaginal epithelium of breast cancer patients","volume":"30","author":"Boccardo, F.; Bruzzi, P.; Rubagotti, A.; Nicol6, G.; Rosso, R.","year":"1981","unstructured":"Boccardo F, Bruzzi P, Rubagotti A, Nicol6 G, Rosso R. Estrogen-like action of tamoxifen on vaginal epithelium of breast cancer patients. Oncology 1981;30:281-5.","journal-title":"Oncology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2303.1990.tb00359.x","article-title":"The effect of tamoxifen on cervical squamous maturation in Papanicolau stained cervical smears of postmenopausal women","volume":"1","author":"Eells, T.P.; Alpern, H.D.; Grzywacz, C.; MacMillan, R.W.; Olson, J.E.","year":"1990","unstructured":"Eells TP, Alpern HD, Grzywacz C, MacMillan RW, Olson JE. The effect of tamoxifen on cervical squamous maturation in Papanicolau stained cervical smears of postmenopausal women. Cytopathology 1990;1:263-8.","journal-title":"Cytopathology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/030089168407000110","article-title":"Endocrine effects of tamoxifen in postmenopausal breast cancer patients","volume":"70","author":"Boccardo, F.; Guarnieri, D.; Rubagotti, A.; Casertelli, G.L.; Bentivoglio, G.; Conte, N.","year":"1984","unstructured":"Boccardo F, Guarnieri D, Rubagotti A, Casertelli GL, Bentivoglio G, Conte N et al. Endocrine effects of tamoxifen in postmenopausal breast cancer patients. Tumori 1984;70:61-8.","journal-title":"Tumori"},{"key":"ref_9","first-page":"660","article-title":"Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen","volume":"81","author":"Lahti, E.; Blanco, G.; Kauppila, A.; Apala-Sarkkinen, M.; Taskinen, P.J.; Laatikainen, T.","year":"1993","unstructured":"Lahti E, Blanco G, Kauppila A, Apala-Sarkkinen M, Taskinen PJ, Laatikainen T. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993;81:660-4.","journal-title":"Obstet Gynecol"},{"key":"ref_10","first-page":"117","article-title":"Adjuvant tamoxifen in early breast cancer: occurrence of new primary tumours","volume":"i:","author":"Fornander, T.; Rutqvist, L.E.; Cedermark, B.; Glas, V.; Mattson, A.; Siltversward, C.","year":"1989","unstructured":"Fornander T, Rutqvist LE, Cedermark B, Glas V, Mattson A, Siltversward C, et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary tumours. Lancet 1989;i: 117-20.","journal-title":"Lancet"},{"key":"ref_11","first-page":"375","article-title":"Tamoxifen and the uterus and endometrium","volume":"i:","author":"Neven, P.; De Muylder, X.; Van Belle, Y.; Venderick, G.; De Muylder, E.","year":"1989","unstructured":"Neven P, De Muylder X, Van Belle Y, Venderick G, De Muylder E. Tamoxifen and the uterus and endometrium. Lancet 1989;i:375.","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00004347-198906000-00005","article-title":"Endometrial polyps in postmenopausal patients receiving tamoxifen","volume":"8","author":"Nuovo, M.A.; Nuovo, G.J.; McCaffrey, R.M.; Levine, R.U.; Barron, B.; Winkler, B.","year":"1989","unstructured":"Nuovo MA, Nuovo GJ, McCaffrey RM, Levine RU, Barron B, Winkler B. Endometrial polyps in postmenopausal patients receiving tamoxifen. Int J Gynecol Pathol 1989;8:125-31.","journal-title":"Int J Gynecol Pathol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1471-0528.1990.tb02536.x","article-title":"Endometrial hyperplasia in an oophorectomized woman receiving tamoxifen therapy. Case report","volume":"97","author":"Cross, S.S.; Ismail, S.M.","year":"1990","unstructured":"Cross SS, Ismail SM. Endometrial hyperplasia in an oophorectomized woman receiving tamoxifen therapy. Case report. BrJ Obstet Gynaecol 1990;97:551-2.","journal-title":"BrJ Obstet Gynaecol"},{"key":"ref_14","first-page":"111","article-title":"Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy","volume":"79","author":"Corley, D.; Rowe, J.; Curtis, M.T.; Hogan, W.M.; Noumoff, J.S.; Livolsi, V.A.","year":"1992","unstructured":"Corley D, Rowe J, Curtis MT, Hogan WM, Noumoff JS, Livolsi VA. Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet Gynecol 1992;79: 111-6.","journal-title":"Obstet Gynecol"},{"key":"ref_15","first-page":"315","article-title":"The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat","volume":"13","author":"Williams, G.M.; Iatropoulos, M.J.; Djordjevic, M.V.; Kaltenberg, O.P.","year":"1993","unstructured":"Williams GM, Iatropoulos MJ, Djordjevic MV, Kaltenberg OP. The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat. Carcinogenesis 1993;13:315-7.","journal-title":"Carcinogenesis"},{"key":"ref_16","first-page":"1360","article-title":"Induction of covalent DNA adducts in rodents by tamoxifen","volume":"52","author":"Han, X.H.; Liehr, J.G.","year":"1992","unstructured":"Han XH, Liehr JG. Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res 1992;52:1360-3.","journal-title":"Cancer Res"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/carcin\/13.12.2197","article-title":"Genotoxic potential of tamoxifen and analogues in female Fischer F344\/n rats, DBA\/2 and C57BLt6 mice and in human MCL-5 cells","volume":"13","author":"White, I.N.H.; De Matteis, F.; Davies, A.","year":"1992","unstructured":"White INH, De Matteis F, Davies A, et al. Genotoxic potential of tamoxifen and analogues in female Fischer F344\/n rats, DBA\/2 and C57BLt6 mice and in human MCL-5 cells. Carcinogenesis 1992;13:2197-203.","journal-title":"Carcinogenesis"},{"key":"ref_18","first-page":"5","article-title":"Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s","volume":"14","author":"Styles, J.A.; Davies, A.; Lim, C.K.; De Matteis, F.; Stanley, L.A.; White, I.N.H.","year":"1994","unstructured":"Styles JA, Davies A, Lim CK, De Matteis F, Stanley LA, White INH, et al. Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s. Carcinogenesis 1994;14:5-9.","journal-title":"Carcinogenesis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00000478-198012000-00004","article-title":"Endometrial epithelial metaplasias: Proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification","volume":"4","author":"Hendrickson, M.R.; Kempson, R.L.","year":"1980","unstructured":"Hendrickson MR, Kempson RL. Endometrial epithelial metaplasias: Proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. Am j Surg Pathol 1980;4:525-42.","journal-title":"Am j Surg Pathol"},{"key":"ref_20","first-page":"40","article-title":"Endometrial polyps","volume":"8","author":"Peterson, W.F.; Novak, E.R.","year":"1956","unstructured":"Peterson WF, Novak ER. Endometrial polyps. Obstet Gynecol 1956;8:40-9.","journal-title":"Obstet Gynecol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1471-0528.1959.tb02009.x","article-title":"Pre-menopausal cystic hyperplasia and endometrial carcinoma","volume":"66","author":"McBride, J.M.","year":"1959","unstructured":"McBride JM. Pre-menopausal cystic hyperplasia and endometrial carcinoma. J Obstet Gynaecol Br Emp 1959;66:288-96.","journal-title":"J Obstet Gynaecol Br Emp"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \"untreated\" hyperplasia in 170 patients","volume":"56","author":"Kurman, R.J.; Kaminski, P.F.; Norris, H.J.","year":"1985","unstructured":"Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of \"untreated\" hyperplasia in 170 patients. Cancer 1985; 56:403-12.","journal-title":"Cancer"},{"key":"ref_23","first-page":"524","article-title":"Sequential relationship between endometrial polyps and carcinoma of the endometrium","volume":"30","author":"Armenia, C.S.","year":"1967","unstructured":"Armenia CS. Sequential relationship between endometrial polyps and carcinoma of the endometrium. Obstet Gynecol 1967;30:524-9.","journal-title":"Obstet Gynecol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198902233200802","article-title":"A randomized clinical trial evaluating tamoxifen in the treatment of patients with node negative breast cancer who have estrogen-receptorpositive tumours","volume":"320","author":"Fisher, B.; Costantino, J.; Redmond, C.; Bowman, D.; Couture, J.; Poisson, R.","year":"1989","unstructured":"Fisher B, Costantino J, Redmond C, Bowman D, Couture J, Poisson R, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node negative breast cancer who have estrogen-receptorpositive tumours. N Engl J Med 1989;320: 479-84.","journal-title":"N Engl J Med"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.47.9.827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:03:13Z","timestamp":1758790993000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.47.9.827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,9]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[1994,9,1]]},"published-print":{"date-parts":[[1994,9]]}},"alternative-id":["10.1136\/jcp.47.9.827"],"URL":"https:\/\/doi.org\/10.1136\/jcp.47.9.827","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,9]]}}}